Dow Spin-Off Pfenex Inks Licensing Pact With Merck For Its Protein Technology
This article was originally published in The Pink Sheet Daily
Executive Summary
The big drug maker will pay as much as $52 million to tap protein expression technology used to make proteins for developing a vaccine candidate.